Fundraising Tactics
    term sheets
    deal evaluation
    funding offers

    How to Compare Venture Term Sheets

    8 min read
    TL;DR

    Compare each term sheet on the same cap table and the same exit scenarios. Record the cash at close, post-close ownership, liquidation and participation rights, exclusivity and expenses. Use the comparison to identify the questions you need to resolve with the investor and your counsel.

    Key takeaways
    • Model liquidation preferences and participation rights at several exit values using the wording and share counts in each offer.
    • Compare post-close cap tables to see who bears the dilution from an option pool increase. The timing and definition of the pool can change the result at the same headline valuation.
    • Check the length of exclusivity and which expenses can still be owed if the financing falls through.
    • Your Series A terms become the negotiation baseline for your Series B, meaning aggressive anti-dilution provisions, unusual board structures, or participating preferences don't disappear, they compound into anchors that future investors will resist and that complicate your next raise.
    • Investor quality at your stage often outweighs valuation: a lower-valuation term sheet from an investor who has built three companies in your category typically delivers more compounding value than a higher valuation from a generalist who disengages after the wire hits.
    How to Compare Venture Term Sheets

    You've done it. After months of pitching, you've got multiple term sheets on the table.

    This should feel like victory. Instead, it feels like paralysis.

    One investor is offering more money but wants a board seat. Another has a lower valuation but includes pro-rata rights that seem aggressive. The third has cleaner terms but a longer close timeline. Your co-founder likes option A. Your advisor says option C. You're reading each term sheet for the fifth time at 2 AM, and the differences are starting to blur together.

    Write the two offers side by side and record which terms produced the difference. Start with the cash that arrives at close, the fully diluted ownership and the rights that matter after signing.

    Then, 18 months later, when they're trying to raise their Series B, those terms come back to haunt them.

    You need a system. Not a lawyer, you should absolutely have one of those too, but a structured way to evaluate multiple offers against each other before the legal review even starts.

    Use one comparison sheet for each offer. Keep the numbers, the open questions and the wording your counsel needs to review together.

    The 2-Hour Term Sheet Comparison System

    This isn't about becoming a securities lawyer overnight. It's about creating a structured evaluation framework that lets you compare offers across the variables that actually matter for your business.

    Two hours. That's how long this should take you once you have the term sheets in hand.

    Hour 1: Build Your Comparison Matrix

    Open a spreadsheet. Create columns for each offer and rows for the categories below.

    Economic Terms

    • Pre-money valuation
    • Investment amount
    • Price per share
    • Post-money valuation
    • Fully diluted ownership percentage
    • Liquidation preference (1x, 2x, participating, non-participating)
    • Anti-dilution protection (full ratchet, broad-based weighted average, none)

    Control Terms

    • Board composition (how many seats, who gets them)
    • Protective provisions (what requires investor approval)
    • Voting rights
    • Information rights
    • Drag-along rights
    • Right of first refusal

    Future Round Implications

    • Pro-rata rights
    • Most favored nation clauses
    • Participation rights in future rounds
    • Any provisions that affect future fundraising

    Timeline and Conditions

    • Due diligence requirements
    • Expected close date
    • Conditions precedent
    • Any unusual contingencies

    Don't just copy the numbers. Translate them into what they mean for you.

    In a simplified hypothetical exit with $15 million available for equity, a $5 million investment carrying an uncapped participating preference at two times its price would receive $10 million before also sharing in the remaining $5 million. Run the example again using the actual seniority, cap and ownership in each offer. The NVCA model documents are a reference for discussing the terms with counsel.

    That matters more than whether the valuation was $18M or $20M pre-money.

    Hour 2: Score Against Your Strategic Priorities

    Now you need to weight these terms against what actually matters for your specific situation.

    Not all term sheets are created equal, and not all companies should optimize for the same things.

    If you're pre-product and need maximum runway:

    Investment amount and investor patience (read: how aggressive the timeline expectations are) matter more than valuation. You need capital and space to figure things out.

    If you're scaling and need operational expertise:

    Board composition and investor value-add become critical. A lower valuation from an investor who's built three marketplace companies is often worth more than higher valuation from a generalist who'll ghost you after the wire hits.

    If you're positioning for a strong Series B in 12-18 months:

    Clean cap table structure and minimal participating preferences matter most. Anything that complicates your next raise is a tax on your future.

    If you're in a competitive market and speed matters:

    Timeline to close might be your most important variable. The best terms in the world don't help if a competitor raises first and blitzes the market while you're still in due diligence.

    Create a simple scoring system. Rate each offer on a 1-10 scale for each category that matters to your situation. Weight the categories based on your strategic priorities.

    I'm not suggesting you reduce this to a pure numbers game, there are intangibles that matter. But forcing yourself to score creates clarity on the trade-offs you're actually making.

    The Variables Most Founders Miss

    After watching this play out hundreds of times, here are the terms that consistently surprise founders when they matter:

    No-shop provisions. Check the exclusivity period, when it begins and what ends it. Ask counsel what conversations you may continue during that period.

    Expense reimbursement. Check whose costs are covered, whether there is a cap and whether anything is payable if the financing falls through. Put each possible cash cost on the comparison sheet.

    Employee option pool. Ask which share count includes the increase and who is diluted under that definition. Compare the fully diluted cap tables on both offers using the proposed pool and investment dates.

    Founder vesting. Compare the schedule, repurchase rights and acceleration language. Ask counsel to model what happens to unvested shares on termination or acquisition.

    These aren't esoteric edge cases. These are terms that appear in standard Series A and Series B term sheets every single week.

    The Three Questions That Cut Through Complexity

    When you're stuck choosing between offers that seem roughly equivalent, ask yourself:

    1. Which investor do I want in the room when things go wrong?

    Not when things are going well, everyone's pleasant during growth. When you miss your targets, when the market shifts, when you need to make a hard pivot. The Question Handling Matrix helps you pattern-match investor behavior during the diligence process, but you should also be back-channeling with founders they've backed before.

    2. Which terms make my next raise easier vs. harder?

    Your Series A terms become the baseline for your Series B. Participating preferences, aggressive anti-dilution, unusual board structures, these all become negotiation anchors that future investors will push back on. Sometimes the best term sheet today creates the easiest path forward, not the maximum valuation.

    3. What's the actual cost of each dollar I'm raising?

    A $3M round at $15M pre-money with clean 1x non-participating terms might be economically better for founders than a $3M round at $18M pre-money with 1.5x participating preferences. Do the math on a few exit scenarios. The answers will surprise you.

    Red Flags That Should Pause the Process

    Some terms aren't just suboptimal, they're signals you should walk away entirely:

    • Full ratchet anti-dilution (means if you ever raise at a lower price, early investors get repriced to the new valuation, massively diluting founders)
    • Redemption rights allowing investors to force you to buy back their shares on a timeline
    • Super-voting shares that give investors control disproportionate to ownership
    • Pay-to-play provisions that punish investors who don't participate in future rounds (creates weird incentives)

    I've also seen founders get excited about term sheets that come with operational requirements buried in the protective provisions, things like requiring investor approval for any hire above a certain salary, or any contract above a certain size. That's not investor protection, that's investor micromanagement.

    Trust your gut. If something feels off about how the negotiation is going, that's data too.

    Making the Decision

    You've built your matrix. You've scored the offers. You've run the numbers on different exit scenarios.

    Now you need to actually choose.

    Here's my framework: pick the offer that gives you the highest probability of building the company you want to build, not the one that looks best on paper.

    That might be the highest valuation. It might not be.

    Compare the milestones each offer funds, the dilution and the operating help each investor can provide. Record which claims the investor has backed up with references.

    Your term sheet isn't just capital. It's choosing your partners for the next 3-5 years minimum.

    After You Choose

    Once you've made your decision, move fast on three things:

    1. Get everything in writing immediately. Send a clear email accepting the term sheet and confirming the key terms. Outline next steps and timeline.

    2. Alert the other investors professionally. You might want to raise from them in the future. "We've decided to move forward with another offer that better aligns with our strategic needs, but we'd love to keep you updated on our progress" leaves doors open.

    3. Start due diligence prep now. Don't wait for the investor to send the list. If you've used the data room assembly checklist before, you know what's coming. Get ahead of it.

    The average time from term sheet to close is 30-45 days. Every day you shave off that timeline is a day you're not burning cash waiting for the wire to hit.

    The Real Win

    The best outcome from this system isn't just choosing the right term sheet, it's understanding exactly what you're signing up for.

    I've never met a founder who regretted being too thorough in their term sheet analysis. I've met dozens who regretted moving too fast and missing implications that became obvious later.

    Two hours of structured comparison work now saves months of regret later.

    And if you're earlier in the process and still working on getting to term sheets in the first place, make sure your deck is telling the story investors need to hear. Analyze your pitch deck to see where you stand before you're choosing between offers.

    The reality: Most founders spend more time choosing their laptop than they spend analyzing their term sheet. Don't be most founders.

    You've built something valuable enough that investors want in. Now make sure you're bringing in the right investors on the right terms.

    Last updated

    Ready to improve your pitch?

    Get your deck scored across 10 VC frameworks in under 10 minutes.